-+ 0.00%
-+ 0.00%
-+ 0.00%

AbCellera shareholders elect John Montalbano, Stephen Quake as Class III directors

PUBT·06/12/2026 16:12:37
Listen to the news
AbCellera shareholders elect John Montalbano, Stephen Quake as Class III directors
  • Abcellera Biologics held its annual shareholder meeting on June 11, 2026.
  • Shareholders ratified Ernst & Young as independent auditor for the fiscal year ending Dec. 31, 2026.
  • Investors backed the board’s nominees for Class III director seats, setting three-year terms running to the 2029 annual meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abcellera Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001703057-26-000033), on June 12, 2026, and is solely responsible for the information contained therein.